0,977  0,001  Monophenol monooxygenase inhibitor
0,903  0,001  Melanin inhibitor
0,902  0,002  Skin whitener
0,888  0,005  Antiinflammatory
0,873  0,004  Antioxidant
0,867  0,003  NOS2 expression inhibitor
0,849  0,004  CYP2C19 substrate
0,850  0,010  Transcription factor NF kappa B inhibitor
0,851  0,011  Apoptosis agonist
0,837  0,003  UGT1A9 substrate
0,838  0,005  Antihypercholesterolemic
0,807  0,005  Chemoprotective
0,807  0,008  TNF expression inhibitor
0,792  0,004  Free radical scavenger
0,788  0,006  Chemopreventive
0,786  0,004  UDP-glucuronosyltransferase substrate
0,741  0,005  Nitric oxide antagonist
0,738  0,004  UGT1A1 substrate
0,730  0,005  Lipoxygenase inhibitor
0,734  0,009  Carcinogenic
0,711  0,005  AR expression inhibitor
0,733  0,028  Alpha-glucosidase inhibitor
0,697  0,014  Antidiabetic
0,697  0,014  Cyclophilin D inhibitor
0,674  0,005  CYP2C19 inhibitor
0,673  0,006  Caspase 3 stimulant
0,685  0,020  Antineoplastic (lung cancer)
0,677  0,015  Antileukemic
0,657  0,004  UGT1A3 substrate
0,650  0,011  Sensitization
0,652  0,013  Respiratory analeptic
0,644  0,014  Antibacterial
0,649  0,028  Antineoplastic (breast cancer)
0,608  0,004  Protein-tyrosine phosphatase 1B inhibitor
0,606  0,010  Antiparasitic
0,608  0,012  Spasmolytic
0,597  0,004  Protein-tyrosine phosphatase inhibitor
0,605  0,013  Mutagenic
0,594  0,011  Hepatic disorders treatment
0,582  0,005  Antihypertriglyceridemic
0,580  0,004  Lipid peroxidase inhibitor
0,588  0,015  Radioprotector
0,573  0,004  VCAM1 expression inhibitor
0,577  0,014  Proliferative diseases treatment
0,563  0,005  Hepatoprotectant
0,545  0,012  Hypoglycemic
0,537  0,004  Breast cancer-resistant protein inhibitor
0,546  0,013  Antineoplastic (glioma)
0,540  0,016  Antiosteoporotic
0,528  0,005  NOS3 expression enhancer
0,539  0,021  Bone diseases treatment
0,519  0,017  Antineoplastic (brain cancer)
0,517  0,018  Lipoprotein disorders treatment
0,515  0,028  Atherosclerosis treatment
0,499  0,017  Antidiabetic (type 2)
0,478  0,003  Aromatase inhibitor
0,505  0,035  Antineoplastic (colorectal cancer)
0,495  0,034  Antineoplastic (colon cancer)
0,514  0,055  Caspase 9 stimulant
0,479  0,023  Cytostatic
0,470  0,014  Vasodilator
0,470  0,014  Antineoplastic enhancer
0,480  0,024  Analeptic
0,474  0,020  Antiprotozoal (Leishmania)
0,479  0,026  Antifungal
0,447  0,002  Ornithine decarboxylase inhibitor
0,461  0,033  Antineoplastic (ovarian cancer)
0,453  0,027  Apoptosis antagonist
0,429  0,004  Cholesterol synthesis inhibitor
0,442  0,017  Vascular (periferal) disease treatment
0,451  0,028  Antineoplastic (pancreatic cancer)
0,460  0,038  Angiogenesis inhibitor
0,426  0,004  Antihemorrhagic
0,439  0,022  Antineoplastic (glioblastoma multiforme)
0,441  0,026  ICAM1 expression inhibitor
0,456  0,045  Immunosuppressant
0,433  0,023  Hypoxia-inducible factor 1 alpha inhibitor
0,432  0,027  Antineoplastic (non-small cell lung cancer)
0,407  0,008  UGT2B15 substrate
0,404  0,005  5-Lipoxygenase inhibitor
0,420  0,022  Hypolipemic
0,409  0,018  Antiulcerative
0,446  0,056  15-Lipoxygenase inhibitor
0,388  0,008  Cyclooxygenase 1 inhibitor
0,413  0,034  Cytotoxic
0,400  0,025  UGT1A6 substrate
0,417  0,043  Streptokinase A inhibitor
0,409  0,036  Cardioprotectant
0,409  0,036  NOS3 expression inhibitor
0,397  0,031  Cardiovascular analeptic
0,400  0,036  Antineoplastic (cervical cancer)
0,423  0,064  Histamine release inhibitor
0,408  0,050  Prostate cancer treatment
0,361  0,004  Estrogen receptor beta antagonist
0,431  0,078  Alzheimer's disease treatment
0,379  0,027  Myocardial infarction treatment
0,351  0,002  Retinoid X alpha receptor agonist
0,402  0,056  CYP2C9 inhibitor
0,360  0,017  Platelet adhesion inhibitor
0,347  0,004  Estrogen receptor alpha antagonist
0,372  0,032  Antihypoxic
0,368  0,030  Amyloid beta aggregation inhibitor
0,399  0,063  CYP3A4 substrate
0,355  0,019  Antimutagenic
0,355  0,019  Antiviral (Herpes)
0,357  0,022  Antihelmintic
0,367  0,034  Tumour necrosis factor alpha release inhibitor
0,346  0,016  Antineoplastic (squamous cell carcinoma)
0,374  0,045  CYP1A2 substrate
0,338  0,010  Neurotrophic factor enhancer
0,397  0,070  Antiprotozoal
0,344  0,019  Antihypotensive
0,325  0,015  Genotoxic
0,298  0,005  Phosphodiesterase 4D inhibitor
0,295  0,004  Papain-like protease (SARS coronavirus) inhibitor
0,296  0,006  Estrogen antagonist
0,306  0,017  Amylase inhibitor
0,342  0,056  Antineoplastic (melanoma)
0,323  0,045  Antiamyloidogenic
0,288  0,012  Heat shock protein 90 antagonist
0,278  0,002  Retinoid X receptor agonist
0,301  0,026  UGT2B7 substrate
0,319  0,047  Platelet antagonist
0,275  0,003  Neuraminidase inhibitor
0,271  0,003  Ca(v)3.1 blocker
0,337  0,078  Antiprotozoal (Plasmodium)
0,270  0,012  Antineoplastic antibiotic
0,309  0,055  CYP1A2 inhibitor
0,275  0,024  MAO inhibitor
0,255  0,006  Estrogen agonist
0,270  0,026  Antineoplastic (carcinoma)
0,316  0,073  CYP2D6 substrate
0,246  0,004  Lipase inhibitor
0,259  0,019  Acetylcholinesterase inhibitor
0,297  0,063  Teratogen
0,266  0,037  UGT1A4 substrate
0,234  0,008  Mucolytic
0,231  0,004  Antiviral (Coronavirus)
0,231  0,004  Antiviral (SARS coronavirus)
0,286  0,063  Antiprotozoal (Trypanosoma)
0,254  0,032  Insulin sensitizer
0,317  0,096  CYP2C9 substrate
0,303  0,086  Antithrombotic
0,239  0,022  Antidiarrheal
0,228  0,012  Topoisomerase II alpha inhibitor
0,277  0,061  Antidiabetic symptomatic
0,274  0,062  Antineoplastic (liver cancer)
0,216  0,011  Beta glucuronidase inhibitor
0,230  0,027  UGT2B9 substrate
0,270  0,067  Embryotoxic
0,207  0,004  Neuraminidase (influenza) inhibitor
0,218  0,018  Arachidonic acid antagonist
0,225  0,032  Cyclooxygenase inhibitor
0,210  0,018  Expectorant
0,209  0,018  Xanthine oxidase inhibitor
0,195  0,004  Ca(v)3.2 blocker
0,278  0,088  Antineoplastic (osteosarcoma)
0,181  0,005  Estrogen receptor beta agonist
0,203  0,029  SULT1A3 substrate
0,184  0,010  Electron transport complex I inhibitor
0,184  0,016  Dementia treatment
0,207  0,040  Antiacne
0,209  0,042  Cholinergic
0,245  0,079  Antipyretic
0,221  0,057  Pneumotoxic
0,179  0,016  Vascular dementia treatment
0,202  0,041  Phospholipase A2 inhibitor
0,186  0,027  Farnesoid X receptor antagonist
0,209  0,053  Antiviral (Hepatitis)
0,213  0,056  P-glycoprotein inhibitor
0,168  0,014  ABCA1 expression enhancer
0,164  0,019  Androgen antagonist
0,181  0,037  Neurotrophic factor
0,183  0,040  Alkaline phosphatase inhibitor
0,250  0,109  12-Lipoxygenase inhibitor
0,146  0,005  Estrogen receptor alpha agonist
0,230  0,090  Antineoplastic (renal cancer)
0,249  0,110  CTGF expression inhibitor
0,177  0,039  Topoisomerase II inhibitor
0,170  0,036  Antiviral (Hepatitis B)
0,235  0,101  UGT2B4 substrate
0,168  0,036  Antitussive
0,255  0,122  Cholesterol antagonist
0,163  0,032  Chelator
0,214  0,083  Antineoplastic (lymphoma)
0,211  0,085  RNA-directed DNA polymerase inhibitor
0,151  0,028  Sulfotransferase substrate
0,137  0,013  Postmenopausal disorders treatment
0,157  0,038  Topoisomerase I inhibitor
0,147  0,033  Photosensitizer
0,172  0,062  Interleukin 6 antagonist
0,173  0,063  Eye irritation, high
0,158  0,051  Adenylate cyclase stimulant
0,217  0,110  Immunostimulant
0,167  0,060  Interferon gamma antagonist
0,140  0,034  UGT2B1 substrate
0,164  0,059  Protein kinase stimulant
0,144  0,039  MAO B inhibitor
0,186  0,084  Antiviral (Influenza)
0,156  0,055  Tubulin antagonist
0,252  0,152  GABA C receptor rho-3 antagonist
0,108  0,009  Leukotriene B4 antagonist
0,153  0,055  Antifungal (Cryptococcus)
0,140  0,043  Microtubule formation inhibitor
0,168  0,071  UGT2B10 substrate
0,113  0,017  SULT1A2 substrate
0,142  0,046  Gastritis treatment
0,136  0,042  TRPA1 agonist
0,190  0,100  Angiogenesis stimulant
0,093  0,004  Retinoic acid alpha receptor agonist
0,148  0,060  Bone formation stimulant
0,109  0,023  Peroxisome proliferator-activated receptor gamma agonist
0,113  0,029  Antibiotic
0,213  0,131  Antineoplastic (multiple myeloma)
0,086  0,007  Squalene synthetase inhibitor
0,134  0,059  DNA polymerase I inhibitor
0,116  0,043  Anabolic
0,099  0,027  Leukotriene synthesis inhibitor
0,110  0,038  SULT1E1 substrate
0,208  0,136  5 Hydroxytryptamine uptake stimulant
0,087  0,015  Fatty acid synthase inhibitor
0,127  0,056  Skin irritative effect
0,136  0,065  Cyclooxygenase 2 inhibitor
0,133  0,063  Carcinogenic, group 3
0,093  0,025  Leukotriene antagonist
0,110  0,042  Antineoplastic alkaloid
0,137  0,071  Contraceptive
0,098  0,033  Na+ K+ transporting ATPase inhibitor
0,115  0,050  Butyrylcholinesterase inhibitor
0,081  0,016  Transcription factor RelA inhibitor
0,206  0,144  Antimycobacterial
0,152  0,092  Dual specificity phosphatase inhibitor
0,115  0,057  Carcinogenic, group 2B
0,096  0,040  Inducible nitric-oxide synthase inhibitor
0,071  0,016  Acetyl-CoA transferase 2 inhibitor
0,105  0,051  UGT2B11 substrate
0,201  0,148  Gastrin inhibitor
0,114  0,062  SULT1A1 substrate
0,069  0,016  Glucose-6-phosphate translocase inhibitor
0,089  0,037  Histidine decarboxylase inhibitor
0,071  0,021  Postcoital contraceptive
0,108  0,061  HDL-cholesterol increasing
0,076  0,031  Exportin-1 inhibitor
0,116  0,073  Alcohol dehydrogenase substrate
0,095  0,052  Actinic keratosis treatment
0,049  0,007  Leukotriene B4 receptor 1 antagonist
0,105  0,062  Toll-Like receptor 4 antagonist
0,088  0,048  Opioid kappa receptor antagonist
0,050  0,012  Retinoid X receptor antagonist
0,179  0,142  Superoxide dismutase inhibitor
0,054  0,017  5-Alpha-reductase inhibitor
0,041  0,006  Retinoic acid receptor agonist
0,064  0,030  Aldose reductase inhibitor
0,078  0,045  CDC25A inhibitor
0,102  0,070  Antihypermotility
0,151  0,123  Abortion inducer
0,033  0,007  Leukotriene B4 receptor 2 antagonist
0,092  0,068  Bile acid receptor antagonist
0,124  0,101  Antidote
0,039  0,016  Retinoid X alpha receptor antagonist
0,124  0,101  Antiviral (Influenza A)
0,117  0,095  Vanilloid 1 agonist
0,083  0,062  Vanilloid agonist
0,111  0,090  Coagulant
0,104  0,085  Beta amyloid protein antagonist
0,115  0,096  Antifungal enhancer
0,206  0,188  Stroke treatment
0,114  0,095  Interleukin 4 antagonist
0,132  0,114  CF transmembrane conductance regulator agonist
0,029  0,014  Retinoid X gamma receptor antagonist
0,076  0,063  Glycine receptor antagonist
0,043  0,030  Opioid kappa receptor agonist
0,055  0,045  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,044  0,035  Neuraminidase (Influenza A) inhibitor
0,093  0,089  GABA C receptor antagonist
0,085  0,081  Antiviral (Hepatitis A)
0,200  0,198  GST M1-1 substrate
0,097  0,095  Cell adhesion inhibitor

